nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT3A—thyroid gland—thyroid cancer	0.0171	0.124	CbGeAlD
Decitabine—DNMT1—saliva-secreting gland—thyroid cancer	0.0169	0.123	CbGeAlD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.0161	0.254	CbGpPWpGaD
Decitabine—DNMT3A—head—thyroid cancer	0.0152	0.11	CbGeAlD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.0133	0.211	CbGpPWpGaD
Decitabine—DNMT1—trachea—thyroid cancer	0.0131	0.095	CbGeAlD
Decitabine—DCK—saliva-secreting gland—thyroid cancer	0.0117	0.0852	CbGeAlD
Decitabine—DNMT3A—lymph node—thyroid cancer	0.0106	0.0772	CbGeAlD
Decitabine—DNMT1—thyroid gland—thyroid cancer	0.0103	0.0752	CbGeAlD
Decitabine—DNMT1—head—thyroid cancer	0.00917	0.0667	CbGeAlD
Decitabine—DCK—trachea—thyroid cancer	0.00904	0.0657	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—MBIP—thyroid cancer	0.0087	0.137	CbGpPWpGaD
Decitabine—DCK—thyroid gland—thyroid cancer	0.00715	0.052	CbGeAlD
Decitabine—DCK—Doxorubicin—Epirubicin—thyroid cancer	0.007	0.519	CbGdCrCtD
Decitabine—DCK—Epirubicin—Doxorubicin—thyroid cancer	0.00647	0.481	CbGdCrCtD
Decitabine—DNMT1—lymph node—thyroid cancer	0.00642	0.0467	CbGeAlD
Decitabine—DCK—head—thyroid cancer	0.00634	0.0461	CbGeAlD
Decitabine—DCK—lymph node—thyroid cancer	0.00444	0.0323	CbGeAlD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.00232	0.0366	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.00192	0.0303	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—thyroid cancer	0.00185	0.0293	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—PPARG—thyroid cancer	0.0017	0.0268	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—CCND1—thyroid cancer	0.00161	0.0254	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—TRIM33—thyroid cancer	0.00132	0.0209	CbGpPWpGaD
Decitabine—Bone pain—Doxorubicin—thyroid cancer	0.00126	0.0016	CcSEcCtD
Decitabine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00126	0.0016	CcSEcCtD
Decitabine—Infection—Sorafenib—thyroid cancer	0.00125	0.00159	CcSEcCtD
Decitabine—Candida infection—Epirubicin—thyroid cancer	0.00124	0.00158	CcSEcCtD
Decitabine—Nervous system disorder—Sorafenib—thyroid cancer	0.00123	0.00157	CcSEcCtD
Decitabine—Dizziness—Vandetanib—thyroid cancer	0.00123	0.00157	CcSEcCtD
Decitabine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00123	0.00157	CcSEcCtD
Decitabine—Blood urea increased—Epirubicin—thyroid cancer	0.00123	0.00157	CcSEcCtD
Decitabine—Skin disorder—Sorafenib—thyroid cancer	0.00122	0.00156	CcSEcCtD
Decitabine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00122	0.00155	CcSEcCtD
Decitabine—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00121	0.00154	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.0012	0.019	CbGpPWpGaD
Decitabine—Anorexia—Sorafenib—thyroid cancer	0.0012	0.00153	CcSEcCtD
Decitabine—Vomiting—Vandetanib—thyroid cancer	0.00119	0.00151	CcSEcCtD
Decitabine—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00119	0.00151	CcSEcCtD
Decitabine—Ecchymosis—Epirubicin—thyroid cancer	0.00118	0.0015	CcSEcCtD
Decitabine—Rash—Vandetanib—thyroid cancer	0.00118	0.0015	CcSEcCtD
Decitabine—Dermatitis—Vandetanib—thyroid cancer	0.00118	0.0015	CcSEcCtD
Decitabine—Headache—Vandetanib—thyroid cancer	0.00117	0.00149	CcSEcCtD
Decitabine—Pulmonary oedema—Epirubicin—thyroid cancer	0.00116	0.00148	CcSEcCtD
Decitabine—Candida infection—Doxorubicin—thyroid cancer	0.00115	0.00147	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00115	0.00146	CcSEcCtD
Decitabine—Blood urea increased—Doxorubicin—thyroid cancer	0.00114	0.00145	CcSEcCtD
Decitabine—Sepsis—Epirubicin—thyroid cancer	0.00113	0.00144	CcSEcCtD
Decitabine—Dyspnoea—Sorafenib—thyroid cancer	0.00112	0.00143	CcSEcCtD
Decitabine—Lymphadenopathy—Epirubicin—thyroid cancer	0.00111	0.00141	CcSEcCtD
Decitabine—Nausea—Vandetanib—thyroid cancer	0.00111	0.00141	CcSEcCtD
Decitabine—Dyspepsia—Sorafenib—thyroid cancer	0.00111	0.00141	CcSEcCtD
Decitabine—Decreased appetite—Sorafenib—thyroid cancer	0.00109	0.00139	CcSEcCtD
Decitabine—Ecchymosis—Doxorubicin—thyroid cancer	0.00109	0.00139	CcSEcCtD
Decitabine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00109	0.00138	CcSEcCtD
Decitabine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00109	0.00138	CcSEcCtD
Decitabine—Fatigue—Sorafenib—thyroid cancer	0.00109	0.00138	CcSEcCtD
Decitabine—Pain—Sorafenib—thyroid cancer	0.00108	0.00137	CcSEcCtD
Decitabine—Constipation—Sorafenib—thyroid cancer	0.00108	0.00137	CcSEcCtD
Decitabine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00107	0.00137	CcSEcCtD
Decitabine—Sepsis—Doxorubicin—thyroid cancer	0.00105	0.00133	CcSEcCtD
Decitabine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00104	0.00133	CcSEcCtD
Decitabine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00103	0.00131	CcSEcCtD
Decitabine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00103	0.00131	CcSEcCtD
Decitabine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00101	0.00128	CcSEcCtD
Decitabine—Urticaria—Sorafenib—thyroid cancer	0.001	0.00127	CcSEcCtD
Decitabine—Body temperature increased—Sorafenib—thyroid cancer	0.000995	0.00127	CcSEcCtD
Decitabine—Abdominal pain—Sorafenib—thyroid cancer	0.000995	0.00127	CcSEcCtD
Decitabine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000978	0.00124	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000966	0.0153	CbGpPWpGaD
Decitabine—Lethargy—Epirubicin—thyroid cancer	0.000966	0.00123	CcSEcCtD
Decitabine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000966	0.00123	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—THRB—thyroid cancer	0.000956	0.0151	CbGpPWpGaD
Decitabine—Hyponatraemia—Epirubicin—thyroid cancer	0.00095	0.00121	CcSEcCtD
Decitabine—Pain in extremity—Epirubicin—thyroid cancer	0.000946	0.0012	CcSEcCtD
Decitabine—Hypersensitivity—Sorafenib—thyroid cancer	0.000927	0.00118	CcSEcCtD
Decitabine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000905	0.00115	CcSEcCtD
Decitabine—Asthenia—Sorafenib—thyroid cancer	0.000903	0.00115	CcSEcCtD
Decitabine—Lethargy—Doxorubicin—thyroid cancer	0.000894	0.00114	CcSEcCtD
Decitabine—DNMT1—Gene Expression—TRIM33—thyroid cancer	0.000894	0.0141	CbGpPWpGaD
Decitabine—Pruritus—Sorafenib—thyroid cancer	0.00089	0.00113	CcSEcCtD
Decitabine—Dehydration—Epirubicin—thyroid cancer	0.00088	0.00112	CcSEcCtD
Decitabine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000879	0.00112	CcSEcCtD
Decitabine—Pain in extremity—Doxorubicin—thyroid cancer	0.000876	0.00111	CcSEcCtD
Decitabine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000874	0.00111	CcSEcCtD
Decitabine—Dry skin—Epirubicin—thyroid cancer	0.000867	0.0011	CcSEcCtD
Decitabine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000864	0.0011	CcSEcCtD
Decitabine—Hypokalaemia—Epirubicin—thyroid cancer	0.000861	0.0011	CcSEcCtD
Decitabine—Diarrhoea—Sorafenib—thyroid cancer	0.000861	0.0011	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000852	0.00108	CcSEcCtD
Decitabine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000846	0.00108	CcSEcCtD
Decitabine—Muscular weakness—Epirubicin—thyroid cancer	0.000835	0.00106	CcSEcCtD
Decitabine—Dizziness—Sorafenib—thyroid cancer	0.000832	0.00106	CcSEcCtD
Decitabine—Abdominal distension—Epirubicin—thyroid cancer	0.000823	0.00105	CcSEcCtD
Decitabine—Dysphagia—Epirubicin—thyroid cancer	0.000818	0.00104	CcSEcCtD
Decitabine—Dehydration—Doxorubicin—thyroid cancer	0.000814	0.00104	CcSEcCtD
Decitabine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000808	0.00103	CcSEcCtD
Decitabine—Dry skin—Doxorubicin—thyroid cancer	0.000803	0.00102	CcSEcCtD
Decitabine—Vomiting—Sorafenib—thyroid cancer	0.0008	0.00102	CcSEcCtD
Decitabine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.0008	0.00102	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.0008	0.0126	CbGpPWpGaD
Decitabine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000797	0.00101	CcSEcCtD
Decitabine—Rash—Sorafenib—thyroid cancer	0.000794	0.00101	CcSEcCtD
Decitabine—Dermatitis—Sorafenib—thyroid cancer	0.000793	0.00101	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000789	0.001	CcSEcCtD
Decitabine—Headache—Sorafenib—thyroid cancer	0.000788	0.001	CcSEcCtD
Decitabine—Bronchitis—Epirubicin—thyroid cancer	0.000787	0.001	CcSEcCtD
Decitabine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000783	0.000997	CcSEcCtD
Decitabine—Pancytopenia—Epirubicin—thyroid cancer	0.000777	0.000989	CcSEcCtD
Decitabine—Muscular weakness—Doxorubicin—thyroid cancer	0.000772	0.000983	CcSEcCtD
Decitabine—Neutropenia—Epirubicin—thyroid cancer	0.000765	0.000973	CcSEcCtD
Decitabine—Dysuria—Epirubicin—thyroid cancer	0.000765	0.000973	CcSEcCtD
Decitabine—Abdominal distension—Doxorubicin—thyroid cancer	0.000762	0.00097	CcSEcCtD
Decitabine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00076	0.000967	CcSEcCtD
Decitabine—DCK—Metabolism—MINPP1—thyroid cancer	0.000759	0.012	CbGpPWpGaD
Decitabine—Dysphagia—Doxorubicin—thyroid cancer	0.000757	0.000963	CcSEcCtD
Decitabine—Pollakiuria—Epirubicin—thyroid cancer	0.000756	0.000962	CcSEcCtD
Decitabine—Nausea—Sorafenib—thyroid cancer	0.000748	0.000951	CcSEcCtD
Decitabine—Weight decreased—Epirubicin—thyroid cancer	0.00074	0.000942	CcSEcCtD
Decitabine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000738	0.000939	CcSEcCtD
Decitabine—Pneumonia—Epirubicin—thyroid cancer	0.000734	0.000934	CcSEcCtD
Decitabine—Infestation—Epirubicin—thyroid cancer	0.000729	0.000928	CcSEcCtD
Decitabine—Infestation NOS—Epirubicin—thyroid cancer	0.000729	0.000928	CcSEcCtD
Decitabine—Bronchitis—Doxorubicin—thyroid cancer	0.000728	0.000926	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—thyroid cancer	0.000719	0.000915	CcSEcCtD
Decitabine—Renal failure—Epirubicin—thyroid cancer	0.000717	0.000912	CcSEcCtD
Decitabine—Stomatitis—Epirubicin—thyroid cancer	0.000711	0.000905	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—thyroid cancer	0.000709	0.000902	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—thyroid cancer	0.000708	0.000901	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—thyroid cancer	0.000708	0.000901	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000703	0.000895	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—thyroid cancer	0.000699	0.00089	CcSEcCtD
Decitabine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00069	0.000878	CcSEcCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—CCND1—thyroid cancer	0.000688	0.0109	CbGpPWpGaD
Decitabine—Epistaxis—Epirubicin—thyroid cancer	0.000688	0.000875	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—thyroid cancer	0.000685	0.000871	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—thyroid cancer	0.000684	0.000871	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000683	0.000869	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—thyroid cancer	0.000679	0.000864	CcSEcCtD
Decitabine—Infestation—Doxorubicin—thyroid cancer	0.000675	0.000859	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—thyroid cancer	0.000675	0.000859	CcSEcCtD
Decitabine—Renal failure—Doxorubicin—thyroid cancer	0.000663	0.000844	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—thyroid cancer	0.000658	0.000837	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—thyroid cancer	0.000658	0.000837	CcSEcCtD
Decitabine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000656	0.000835	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—thyroid cancer	0.000655	0.000833	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000651	0.000829	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—thyroid cancer	0.00065	0.000827	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000647	0.000823	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—TPR—thyroid cancer	0.000646	0.0102	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—THRB—thyroid cancer	0.000646	0.0102	CbGpPWpGaD
Decitabine—DCK—Metabolism—NDUFA13—thyroid cancer	0.000645	0.0102	CbGpPWpGaD
Decitabine—Oedema peripheral—Epirubicin—thyroid cancer	0.000645	0.000821	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000643	0.000819	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—thyroid cancer	0.000642	0.000817	CcSEcCtD
Decitabine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000638	0.000812	CcSEcCtD
Decitabine—Epistaxis—Doxorubicin—thyroid cancer	0.000636	0.00081	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000636	0.0101	CbGpPWpGaD
Decitabine—Sinusitis—Doxorubicin—thyroid cancer	0.000633	0.000806	CcSEcCtD
Decitabine—Eye disorder—Epirubicin—thyroid cancer	0.000612	0.000779	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—thyroid cancer	0.000609	0.000775	CcSEcCtD
Decitabine—Cardiac disorder—Epirubicin—thyroid cancer	0.000608	0.000773	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—MEN1—thyroid cancer	0.000607	0.0096	CbGpPWpGaD
Decitabine—DCK—Metabolism—CHST14—thyroid cancer	0.000607	0.00958	CbGpPWpGaD
Decitabine—Haemorrhage—Doxorubicin—thyroid cancer	0.000606	0.000771	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000603	0.000767	CcSEcCtD
Decitabine—Pharyngitis—Doxorubicin—thyroid cancer	0.000601	0.000765	CcSEcCtD
Decitabine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000598	0.000761	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000597	0.000759	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000595	0.000758	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—thyroid cancer	0.000594	0.000756	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—thyroid cancer	0.000594	0.000756	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—thyroid cancer	0.000591	0.000753	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00059	0.000751	CcSEcCtD
Decitabine—Chills—Epirubicin—thyroid cancer	0.000587	0.000748	CcSEcCtD
Decitabine—Alopecia—Epirubicin—thyroid cancer	0.000579	0.000736	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—thyroid cancer	0.000574	0.00073	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—thyroid cancer	0.00057	0.000725	CcSEcCtD
Decitabine—Erythema—Epirubicin—thyroid cancer	0.00057	0.000725	CcSEcCtD
Decitabine—Eye disorder—Doxorubicin—thyroid cancer	0.000566	0.00072	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000562	0.000716	CcSEcCtD
Decitabine—Back pain—Epirubicin—thyroid cancer	0.000551	0.000702	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—thyroid cancer	0.00055	0.000699	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—thyroid cancer	0.000548	0.000697	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—thyroid cancer	0.000547	0.000696	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000546	0.000695	CcSEcCtD
Decitabine—Chills—Doxorubicin—thyroid cancer	0.000544	0.000692	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—thyroid cancer	0.000537	0.000684	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—thyroid cancer	0.000535	0.000681	CcSEcCtD
Decitabine—Mental disorder—Doxorubicin—thyroid cancer	0.000531	0.000675	CcSEcCtD
Decitabine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000529	0.000673	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—thyroid cancer	0.000527	0.000671	CcSEcCtD
Decitabine—Erythema—Doxorubicin—thyroid cancer	0.000527	0.000671	CcSEcCtD
Decitabine—Anaemia—Epirubicin—thyroid cancer	0.000527	0.00067	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000527	0.00832	CbGpPWpGaD
Decitabine—Malaise—Epirubicin—thyroid cancer	0.000514	0.000654	CcSEcCtD
Decitabine—Leukopenia—Epirubicin—thyroid cancer	0.00051	0.000649	CcSEcCtD
Decitabine—Back pain—Doxorubicin—thyroid cancer	0.00051	0.000649	CcSEcCtD
Decitabine—Muscle spasms—Doxorubicin—thyroid cancer	0.000507	0.000645	CcSEcCtD
Decitabine—Cough—Epirubicin—thyroid cancer	0.000497	0.000633	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—thyroid cancer	0.000497	0.000633	CcSEcCtD
Decitabine—Hypertension—Epirubicin—thyroid cancer	0.000492	0.000626	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000489	0.000623	CcSEcCtD
Decitabine—DCK—Metabolism—HPGD—thyroid cancer	0.000489	0.00773	CbGpPWpGaD
Decitabine—Anaemia—Doxorubicin—thyroid cancer	0.000487	0.00062	CcSEcCtD
Decitabine—Chest pain—Epirubicin—thyroid cancer	0.000485	0.000618	CcSEcCtD
Decitabine—Myalgia—Epirubicin—thyroid cancer	0.000485	0.000618	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—thyroid cancer	0.000485	0.000618	CcSEcCtD
Decitabine—Anxiety—Epirubicin—thyroid cancer	0.000484	0.000615	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000482	0.000613	CcSEcCtD
Decitabine—Discomfort—Epirubicin—thyroid cancer	0.000479	0.00061	CcSEcCtD
Decitabine—Malaise—Doxorubicin—thyroid cancer	0.000476	0.000605	CcSEcCtD
Decitabine—Leukopenia—Doxorubicin—thyroid cancer	0.000472	0.000601	CcSEcCtD
Decitabine—Confusional state—Epirubicin—thyroid cancer	0.000469	0.000597	CcSEcCtD
Decitabine—Oedema—Epirubicin—thyroid cancer	0.000465	0.000592	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000465	0.000592	CcSEcCtD
Decitabine—Infection—Epirubicin—thyroid cancer	0.000462	0.000588	CcSEcCtD
Decitabine—Cough—Doxorubicin—thyroid cancer	0.00046	0.000586	CcSEcCtD
Decitabine—Nervous system disorder—Epirubicin—thyroid cancer	0.000456	0.000581	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000455	0.00058	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—thyroid cancer	0.000455	0.000579	CcSEcCtD
Decitabine—Tachycardia—Epirubicin—thyroid cancer	0.000454	0.000578	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—thyroid cancer	0.000452	0.000575	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—thyroid cancer	0.000449	0.000571	CcSEcCtD
Decitabine—Arthralgia—Doxorubicin—thyroid cancer	0.000449	0.000571	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—thyroid cancer	0.000449	0.000571	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—thyroid cancer	0.000447	0.000569	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000446	0.000567	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—thyroid cancer	0.000444	0.000565	CcSEcCtD
Decitabine—Anorexia—Epirubicin—thyroid cancer	0.000443	0.000564	CcSEcCtD
Decitabine—DNMT1—Gene Expression—TPR—thyroid cancer	0.000436	0.00689	CbGpPWpGaD
Decitabine—Hypotension—Epirubicin—thyroid cancer	0.000435	0.000553	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—thyroid cancer	0.000434	0.000552	CcSEcCtD
Decitabine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00043	0.000548	CcSEcCtD
Decitabine—Oedema—Doxorubicin—thyroid cancer	0.00043	0.000548	CcSEcCtD
Decitabine—Infection—Doxorubicin—thyroid cancer	0.000428	0.000544	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000424	0.000539	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000422	0.000537	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000421	0.000536	CcSEcCtD
Decitabine—Insomnia—Epirubicin—thyroid cancer	0.000421	0.000535	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—thyroid cancer	0.00042	0.000535	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—thyroid cancer	0.000418	0.000532	CcSEcCtD
Decitabine—Dyspnoea—Epirubicin—thyroid cancer	0.000415	0.000528	CcSEcCtD
Decitabine—DNMT1—Gene Expression—MEN1—thyroid cancer	0.00041	0.00648	CbGpPWpGaD
Decitabine—Anorexia—Doxorubicin—thyroid cancer	0.00041	0.000522	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—thyroid cancer	0.000409	0.000521	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—RXRA—thyroid cancer	0.000406	0.00642	CbGpPWpGaD
Decitabine—Decreased appetite—Epirubicin—thyroid cancer	0.000404	0.000515	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—thyroid cancer	0.000402	0.000512	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000402	0.000511	CcSEcCtD
Decitabine—Fatigue—Epirubicin—thyroid cancer	0.000401	0.00051	CcSEcCtD
Decitabine—Pain—Epirubicin—thyroid cancer	0.000398	0.000506	CcSEcCtD
Decitabine—Constipation—Epirubicin—thyroid cancer	0.000398	0.000506	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000392	0.000499	CcSEcCtD
Decitabine—Insomnia—Doxorubicin—thyroid cancer	0.000389	0.000495	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—thyroid cancer	0.000384	0.000488	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—thyroid cancer	0.000383	0.000488	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00038	0.000484	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—thyroid cancer	0.000379	0.000482	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—thyroid cancer	0.000374	0.000476	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000372	0.000473	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—thyroid cancer	0.000371	0.000472	CcSEcCtD
Decitabine—Urticaria—Epirubicin—thyroid cancer	0.00037	0.00047	CcSEcCtD
Decitabine—Pain—Doxorubicin—thyroid cancer	0.000368	0.000468	CcSEcCtD
Decitabine—Constipation—Doxorubicin—thyroid cancer	0.000368	0.000468	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—thyroid cancer	0.000368	0.000468	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—thyroid cancer	0.000368	0.000468	CcSEcCtD
Decitabine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000355	0.000451	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000352	0.000448	CcSEcCtD
Decitabine—Hypersensitivity—Epirubicin—thyroid cancer	0.000343	0.000436	CcSEcCtD
Decitabine—Urticaria—Doxorubicin—thyroid cancer	0.000342	0.000435	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—thyroid cancer	0.00034	0.000433	CcSEcCtD
Decitabine—Body temperature increased—Doxorubicin—thyroid cancer	0.00034	0.000433	CcSEcCtD
Decitabine—Asthenia—Epirubicin—thyroid cancer	0.000334	0.000425	CcSEcCtD
Decitabine—Pruritus—Epirubicin—thyroid cancer	0.000329	0.000419	CcSEcCtD
Decitabine—Diarrhoea—Epirubicin—thyroid cancer	0.000318	0.000405	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000317	0.000404	CcSEcCtD
Decitabine—Asthenia—Doxorubicin—thyroid cancer	0.000309	0.000393	CcSEcCtD
Decitabine—Dizziness—Epirubicin—thyroid cancer	0.000308	0.000391	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—thyroid cancer	0.000304	0.000388	CcSEcCtD
Decitabine—Vomiting—Epirubicin—thyroid cancer	0.000296	0.000376	CcSEcCtD
Decitabine—Diarrhoea—Doxorubicin—thyroid cancer	0.000294	0.000375	CcSEcCtD
Decitabine—Rash—Epirubicin—thyroid cancer	0.000293	0.000373	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—thyroid cancer	0.000293	0.000373	CcSEcCtD
Decitabine—Headache—Epirubicin—thyroid cancer	0.000291	0.000371	CcSEcCtD
Decitabine—Dizziness—Doxorubicin—thyroid cancer	0.000285	0.000362	CcSEcCtD
Decitabine—DCK—Metabolism—TPR—thyroid cancer	0.000281	0.00444	CbGpPWpGaD
Decitabine—DCK—Metabolism—PRKAR1A—thyroid cancer	0.000276	0.00437	CbGpPWpGaD
Decitabine—Nausea—Epirubicin—thyroid cancer	0.000276	0.000352	CcSEcCtD
Decitabine—DNMT1—Gene Expression—RXRA—thyroid cancer	0.000274	0.00434	CbGpPWpGaD
Decitabine—Vomiting—Doxorubicin—thyroid cancer	0.000274	0.000348	CcSEcCtD
Decitabine—Rash—Doxorubicin—thyroid cancer	0.000271	0.000345	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—thyroid cancer	0.000271	0.000345	CcSEcCtD
Decitabine—Headache—Doxorubicin—thyroid cancer	0.00027	0.000343	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—PPARG—thyroid cancer	0.000257	0.00405	CbGpPWpGaD
Decitabine—Nausea—Doxorubicin—thyroid cancer	0.000256	0.000325	CcSEcCtD
Decitabine—DCK—Metabolism—SLC5A5—thyroid cancer	0.00021	0.00332	CbGpPWpGaD
Decitabine—DCK—Metabolism—RXRA—thyroid cancer	0.000177	0.00279	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PPARG—thyroid cancer	0.000173	0.00274	CbGpPWpGaD
Decitabine—DCK—Metabolism—PPARG—thyroid cancer	0.000112	0.00176	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—AKT1—thyroid cancer	0.000101	0.0016	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTGS2—thyroid cancer	8.77e-05	0.00139	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTEN—thyroid cancer	7.65e-05	0.00121	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—AKT1—thyroid cancer	6.85e-05	0.00108	CbGpPWpGaD
Decitabine—DCK—Metabolism—AKT1—thyroid cancer	4.41e-05	0.000697	CbGpPWpGaD
